Antibiotic Prescribing Patterns in Paediatric Primary Care in Italy: Findings from 2012-2018

Elisa Barbieri1, Costanza di Chiara1, Paola Costenaro1

  • 1Division of Paediatric Infectious Diseases, Department for Woman and Child Health, University of Padua, 35100 Padua, Italy.

Insights

Antibiotic prescriptions in Italian children decreased yearly, but preschoolers still receive over one annually. Broad-spectrum antibiotic use remains high, indicating a need for improved antibiotic stewardship.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic stewardship programs are crucial for monitoring and optimizing antibiotic use.
  • Understanding prescribing patterns in pediatric primary care is essential for effective stewardship.

Purpose of the Study:

  • To evaluate antibiotic prescribing trends in Italian pediatric primary care from 2012 to 2018.
  • To analyze treatment switching and prolongation patterns for pediatric antibiotic prescriptions.

Main Methods:

  • A database study utilizing the Pedianet pediatric primary care database (2012-2018).
  • Descriptive analyses stratified by diagnosis, year, and age.
  • Generalized linear Poisson regression to assess prescription variations.

Main Results:

  • A significant yearly decrease of 4% in antibiotic prescriptions per child was observed (0.79 in 2012 to 0.62 in 2018).
  • Amoxicillin use decreased with age, while macrolides and third-generation cephalosporins increased.
  • Upper respiratory infections were the most common diagnosis (23%), followed by pharyngitis (21%).
  • Eight percent of treatments involved class switches or prolongations, primarily with co-amoxiclav, macrolides, and third-generation cephalosporins.

Conclusions:

  • While overall antibiotic prescriptions declined, preschoolers exceeded one prescription annually.
  • High rates of broad-spectrum antibiotic use persist, highlighting ongoing stewardship challenges.
  • Further interventions are needed to optimize antibiotic prescribing in pediatric primary care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.1K